[1]马红红,张启龙,刘娜娜,等.沙库巴曲缬沙坦对原发性高血压的治疗效果及机制研究[J].陕西医学杂志,2023,52(10):1384-1387.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.022]
　MA Honghong,ZHANG Qilong,LIU Nana,et al.Therapeutic effect and mechanism of sacubitril/valsartan in patients with essential hypertension[J].,2023,52(10):1384-1387.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.022]
点击复制

沙库巴曲缬沙坦对原发性高血压的治疗效果及机制研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年10期
页码:
1384-1387
栏目:
药物与临床
出版日期:
2023-10-05

文章信息/Info

Title:
Therapeutic effect and mechanism of sacubitril/valsartan in patients with essential hypertension
作者:
马红红; 张启龙; 刘娜娜; 马艳梅
(榆林市第一医院,陕西 榆林 719000)
Author(s):
MA Honghong; ZHANG Qilong; LIU Nana; MA Yanmei
(The First Hospital of Yulin,Yulin 719000,China)
关键词:
原发性高血压;  血管内皮细胞;  磷脂酰肌醇3激酶;  丝氨酸苏氨酸蛋白激酶;  沙库巴曲缬沙坦
Keywords:
Essential hypertension;  Vascular endothelial cells;  Phosphatidyl inositol 3 kinase;  Serine threonine protein kinase;  Sacubitril/valsartan
分类号:
R 544.1
DOI:
DOI:10.3969/j.issn.1000-7377.2023.10.022
文献标志码:
A
摘要:
目的:探讨沙库巴曲缬沙坦对原发性高血压(EH)的治疗效果,并分析其可能机制。方法:随机数字表法将168例EH患者均分为两组,其中对照组服用替米沙坦降低血压,观察组服用沙库巴曲缬沙坦降血压,两组均持续服用12周。比较两组治疗前后血压(收缩压、舒张压)、氧化应激[晚期氧化蛋白产物(AOPP)、超氧化物歧化酶(SOD)、一氧化氮(NO)]、炎症反应[白细胞介素-1(IL-1)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)]、PI3K/AKT信号蛋白[PI3K、AKT、磷酸化丝氨酸苏氨酸蛋白激酶(p-AKT)]及血管内皮功能[血管内皮细胞(VEC)数目、VEC表达频率、血管内皮舒张功能(FMD)、血管内皮功能障碍]变化情况。结果:与治疗前比,两组治疗后收缩压、舒张压、AOPP、NO、IL-1、IL-6、TNF-α、p-AKT、血管内皮功能障碍发生率均明显下降,血清SOD、PI3K、AKT、VEC数目、VEC表达频率、FMD明显增大(均P<0.05)。观察组治疗后的收缩压、舒张压、AOPP、NO、IL-1、IL-6、TNF-α、p-AKT、血管内皮功能障碍发生率均明显低于对照组,血清SOD、PI3K、AKT、VEC数目、VEC表达频率、FMD明显大于对照组(均P<0.05)。结论:沙库巴曲缬沙坦具有良好的降血压作用,同时可通过调节PI3K/AKT信号通路,抑制EH体内氧化应激和炎症反应,促进患者VEC增殖,逆转血管内皮损伤。
Abstract:
Objective:To investigate the therapeutic effect of sacubitril/valsartan on essential hypertension(EH)and its possible mechanism.Methods:A total of 168 EH patients were divided into two groups by random number table method.Telmisartan was taken in control group to reduce blood pressure,and sacubitril/valsartan was taken in observation group to reduce blood pressure,and both groups continued to take medicine for 12 weeks.Blood pressure(systolic blood pressure,diastolic blood pressure),oxidative stress(advanced oxidized protein product [AOPP],superoxide dismutase [SOD],nitric oxide [NO]),inflammatory response(interleukin-1 [IL-1],interleukin-6 [IL-6],tumor necrosis factor-α [TNF-α]),phosphatidyl inositol 3 kinase/serine threonine protein kinase(PI3K/AKT)signaling protein(PI3K,AKT,phosphorylated serine threonine protein kinase [p-AKT])and vascular endothelial function(number of vascular endothelial cells [VEC],frequency of VEC expression,vascular endothelial diastolic function [FMD],vascular endothelial dysfunction)were compared between the two groups before and after treatment.Results:Compared with before treatment,systolic blood pressure,diastolic blood pressure,AOPP,NO,IL-1,IL-6,TNF-α,p-AKT and incidence of vascular endothelial dysfunction were significantly decreased in two groups after treatment,and serum SOD,PI3K,AKT,VEC number,VEC expression frequency and FMD were significantly increased(all P<0.05).The systolic blood pressure,diastolic blood pressure,AOPP,NO,IL-1,IL-6,TNF-α,p-AKT and incidence of vascular endothelial dysfunction in the observation group were significantly lower than those in the control group,while the serum SOD,PI3K,AKT,VEC number,VEC expression frequency and FMD were significantly higher than those in the control group(all P<0.05).Conclusion:Sacubitril/valsartan has a good effect on lowering blood pressure,and can inhibit oxidative stress and inflammation in EH by regulating PI3K/AKT signaling pathway,promote VEC proliferation and reverse vascular endothelial injury.

参考文献/References:

[1] 胡文君,张 振,戴 敏.丹皮酚通过抑制PI3K/AKT-NF-κB通路对LPS诱导的与平滑肌细胞共培养的大鼠血管内皮细胞的保护作用[J].中国中药杂志,2016,41(12):2298-2302.
[2] 郭 芬,王晓雪.柚皮苷调控PI3K/Akt/eNOS通路控制2型糖尿病大鼠脑血管内皮氧化损伤的作用探讨[J].安徽医药,2021,25(4):645-649.
[3] 李 悦,李梦杰,张 蕾,等.PI3K/Akt/mTOR信号通路稳态与心血管疾病的研究进展[J].医学综述,2020,26(23):4604-4611.
[4] Falkner B,Lurbe E.Primary hypertension beginning in childhood and risk for future cardiovascular disease[J].J Pediatr,2021,238(1):16-25.
[5] 张 跃,李 宁,邱 健,等.血管紧张素受体脑啡肽酶抑制剂沙库巴曲缬沙坦治疗高血压的研究进展[J].中华高血压杂志,2021,29(6):519-524.
[6] 《中国高血压防治指南》修订委员会.中国高血压防治指南2018年修订版[J].心脑血管病防治,2019,19(1):1-44.
[7] 夏文豪,董 兵,刘晓玲,等.衰老成血管T细胞与高血压患者血管内皮功能障碍及炎症状态的相关性[J].中华高血压杂志,2021,29(10):972-980.
[8] 孙国星,范 虹,高晶晶,等.长安雷氏心病痰瘀流派“痰瘀毒风”理论辨治高血压病[J].陕西中医,2022,43(12):1787-1789.
[9] 李令建,汤艳萍,左常阳.不同介入时间电针治疗对脑缺血后脑组织Bax、Bcl-2表达及PI3K/AKT信号通路的影响[J].广东医学,2017,38(23):3571-3576.
[10] Zhang Q,Wang Z,Zhu J,et al.Ferulic acid regulates miR-17/PTEN axis to inhibit LPS-induced pulmonary microvascular endothelial cells apoptosis through activation of PI3K/Akt pathway[J].J Toxicol Sci,2022,47(2):61-69.
[11] Sun N,Wang H,Wang L.Vaspin alleviates dysfunction of endothelial progenitor cells induced by high glucose via PI3K/Akt/eNOS pathway[J].Int J Clin Exp Pathol,2015,8(1):482-489.
[12] 羡微微,刘桂清.沙库巴曲缬沙坦对射血分数降低性心衰患者血浆去甲肾上腺素和血清心肌肌钙蛋白I水平的影响研究[J].陕西医学杂志,2020,49(10):1306-1309.
[13] 托合提古丽?亚森,李红建.沙库巴曲缬沙坦降压疗效及其对高血压患者靶器官损害的影响[J].中国医药,2022,17(5):768-771.
[14] 周娇鸣,王永红.沙库巴曲缬沙坦治疗老年高血压的疗效及安全性分析[J].中华保健医学杂志,2022,24(2):99-101.
[15] 刘 哲,刘易婷,王 晶.沙库巴曲缬沙坦联合达格列净治疗2型糖尿病合并心力衰竭临床疗效观察[J].陕西医学杂志,2022,51(3):355-358.
[16] Lin XP,Cui HJ,Yang AL,et al.Astragaloside IV improves vasodilatation function by regulating the PI3K/Akt/eNOS signaling pathway in rat aorta endothelial cells[J].Vasc Res,2018,55(3):169-176.
[17] 肖高春,童仕伦,郑勇斌,等.PI3K/AKT及MEK/ERK信号通路在肿瘤血管内皮细胞迁移中的作用[J].重庆医学,2015,44(11):1452-1456.
[18] 童星丽,谈 勇,殷燕云,等.基于PI3K/Akt信号通路探讨丹参酮Ⅱ_(A)调控血管内皮细胞活化因子表达的实验研究[J].中国中药杂志,2022,47(13):3589-3596.
[19] 李 雯,戚 迪,陈 兰,等.Vaspin通过PI3K/Akt通路发挥抗炎及血管内皮保护作用减轻脂多糖致急性呼吸窘迫综合征小鼠肺损伤[J].南方医科大学学报,2018,38(3):283-288.

相似文献/References:

[1]陈玉菲,杨 萍.高龄老年住院原发性高血压合并高尿酸血症发病情况及相关因素分析[J].陕西医学杂志,2019,(6):725.
[2]刘玉珊.老年动脉粥样硬化性心肌梗死患者血清胱抑素C水平与血管内皮细胞损伤相关性研究*[J].陕西医学杂志,2020,49(4):431.
　LIU Yushan..Relationship between serum cystatin C level and vascular endothelial cell injury in elderly patients with atherosclerotic myocardial infarction[J].,2020,49(10):431.
[3]武卫党,石 磊,张丹凤△,等.达格列净对糖尿病心肌缺血大鼠心肌功能改善作用的实验研究*[J].陕西医学杂志,2020,49(7):778.[doi:DOI:10.3969/j.issn.10007377.2020.07.003]
[4]王 琦,杨 华,郭西伟.原发性高血压患者血清三碘甲状腺原氨酸、四碘甲状腺原氨酸、25羟基维生素D3水平与血压昼夜节律关系分析[J].陕西医学杂志,2022,51(10):1282.[doi:DOI:10.3969/j.issn.1000-7377.2022.10.026]

备注/Memo

备注/Memo:
基金项目:陕西省重点研发计划项目(YF-2020-039)
更新日期/Last Update: 2023-10-07